Released on: February 20, 2008, 12:37 am

Press Release Author: Shushmul Maheshwari

Industry: Healthcare

Press Release Summary: Brazil, one of the major emerging powers of the world, is
marking its presence in almost every dimension of the world economy, including the
generic drugs industry. Identifying the importance of the country in this
significant domain, the leading market research firm, RNCOS, has come up with
research report “Generic Drugs Market in Brazil (2007-2011)” to provide
an updated and detailed account of the Brazilian generic drugs industry.

Press Release Body: Brazil, one of the major emerging powers of the world, is
marking its presence in almost every dimension of the world economy, including the
generic drugs industry. Identifying the importance of the country in this
significant domain, the leading market research firm, RNCOS, has come up with
research report “Generic Drugs Market in Brazil (2007-2011)” to provide
an updated and detailed account of the Brazilian generic drugs industry. It examines
the chief reasons why all major generic players are heading to Brazil to manufacture
and sell their drugs.

Brazil is currently the largest market for generic drugs in Latin America and with
the current scenario and positive future projections; it is likely to emerge amongst
the most potential markets for generic drugs in the world.

The generic drugs market in Brazil witnessed an explosive growth of 38.8% and was
valued in excess of US$ 1 Billion in 2006. The market was driven by several factors
such as a supporting political environment, lower cost and patent expirations of
several blockbuster drugs. The market is presently being dominated by domestic
generic manufacturers; however, the presence of foreign firms in the market is
increasing rapidly.

The growth of the market is expected to remain strong with generics expected to
occupy 22.8% of the total market by 2011, enabling Brazil to become one of the
largest generic markets in the world. However, despite the strong growth, several
challenges still remain to be tackled, including the prevalence of cheaper
non-bioequivalent “similar drugs”, low prescriptions from the private
sector, and low penetration levels in the private sector.

Key Issues & Facts Analyzed

- Evaluation of past, current and future market trends.
- Discussion about the size and growth of the market.
- Analysis of healthcare indicators.
- Future prospects of the generics market.
- Analysis of various challenges and opportunities before the industry.
- Profile discussion of key players in this sector.

Key Players Analyzed

This section provides the overview, key facts, and financial information of
prominent players in the Brazil Generics Market, such as Medley, EMS Sigma Pharma,
Eurofarma Laboratorios Ltd, Aché Pharmaceutical Laboratories S/A and Ranbaxy.

Research Methodology Used

Information Sources

The information has been sourced from books, newspapers, trade journals, and white
papers, industry portals, government agencies, trade associations, monitoring
industry news and developments, and over 3000 paid databases.

Analysis Methods

The analysis methods include ratio analysis, historical trend analysis, linear
regression analysis using software tools, judgmental forecasting, and cause and
effect analysis.

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit: http://www.rncos.com/Report/IM572.htm
Current Industry News: http://www.rncos.com/Blog/


Web Site: http://www.rncos.com/

Contact Details: 29, 1st Floor, Patparganj Industrial Area, Delhi-92
91-11-4214-1229
91-11-4214-1228
info@rncos.com